Association between the Presence of Autoantibodies against Adrenoreceptors and Severe Pre-Eclampsia: A Pilot Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ma, Guiling ^a   Li, Yanfang ^a   Zhang, Juan ^a   Liu, Hao ^a   Hou, Dongyan ^a   Zhu, Lei ^a   Zhang, Zhenyu ^a   Zhang, Lin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR ANTIBODY; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR ANTIBODY; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR ANTIBODY; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ANTIBODY TITER; ARTICLE; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FETUS; FETUS DISTRESS; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DEATH; PILOT STUDY; PREECLAMPSIA; PREGNANCY; RISK FACTOR;

ADULT; APGAR SCORE; AUTOANTIBODIES; BIRTH WEIGHT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; ORGAN SIZE; PILOT PROJECTS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, ADRENERGIC; TREATMENT OUTCOME;

EID: 84874593836     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057983     Document Type: Article

References (27)

1. Roberts JM, Pearson G, Cutler F, Lindheimer M, (2003) Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 41(3): 437-445.
2. Hutcheon JA, Lisonkova S, Joseph KS, (2011) Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Cl Ob 25(4): 391-403.
3. Redman CW, Sargent IL, (2005) Latest advances in understanding preeclampsia. Science 308(5728): 1592-1594.
4. Roberts JM, Lain KY, (1998) Obstetrics. Preterm birth and preeclampsia bad news and good news. Lancet 352: SIV22.
5. Fu MLX, Herlitz H, Wallukat G, Hilme E, Hedner T, et al. (1994) Functional autoimmune epitope on α1-adrenoreceptors in patients with malignant hypertension. Lancet 334(8938): 1660-1663.
6. Luther HP, Homuth V, Wallukat G, (1997) α1-Adrenergic receptor antibodies in patients with primary hypertension. Hypertension 29(2): 678-682.
7. Lin Z, Jian Z, Zhenyin T, Yanli S, Rutai H, et al. (1998) Study of Auto-antibodies Against G-protien Coupled β1 and M2 Receptors in Patients with Hypertensive Heart Diseases. Chin J Hypertens 6(1): 5-8.
8. Lei Z, Shuyan W, Guobin M, Xiulan L, Lin Z, (2003) The correlation of autoantibodies against G-protein-coupled β2- and α1-adrenergic and angiotension II-1 receptors in patients with primary hypertension. Chin J Clin Rehab 7(15): 2160-2161.
9. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, et al. (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103(7): 945-952.
10. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, et al. (2000) AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101(20): 2382-2387.
11. Dechend R, Viedt C, Müller DN, Ugele B, Brandes RP, et al. (2003) AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107(12): 1632-1639.
12. Bobst SM, Day MC, Gilstrap LC, Xia Y, Kellems RE, (2005) Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 18(3): 330-336.
13. Zhou CC, Ahmad S, Mi T, Abbasi S, Xia L, et al. (2008) Autoantibody from women with preeclampsia induces soluble fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated t-cells signaling. Hypertension 51(4): 1010-1019.
14. Apgar Virginia, (1953) A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 32(4): 260-267.
15. Dietl J, (2000) The pathogenesis of preeclampsia: new aspects. J perinat Med 28(6): 464-471.
16. Redman CW, Sargent IL, (2003) Preeclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 24 (Suppl A): S21-S27.
17. Dekker GA, Sibai BM, (1999) The immunology of preeclampsia. Semin perinaton 23(1): 24-33.
18. Lee RM, Brown MA, Branch DW, Ward K, Silver RM, (2003) Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 102(2): 294-300.
19. Walsh DA, Van Patten SM, (1994) Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB 8(15): 1227-1236.
20. Graham RM, Perez DM, Hwa J, Piascik MT, (1996) a1-Adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 78(5): 737-749.
21. Bellamy L, Casas JP, Hingorani AD, Williams DJ, (2007) Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335(7627): 974-985.
22. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ, (2008) Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 156(5): 918-930.
23. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183(1): 1-22.
24. Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, et al. (1987) Cloning of the cDNA for the human β1-adrenergic receptor. Proc Natl Acad Sci USA 84(2): 7920-7924.
25. Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, et al. (1987) cDNA for the human β2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84(1): 46-50.
26. Lomasney JW, Cotecchia S, Lorenz W, Leung WY, Schwinn DA, et al. (1991) Molecular cloning and expression of the cDNA for the α1A-adrenergic receptor. J Biol Chem 266(10): 6365-6369.
27. Fu ML, Hoebeke J, Matsui S, Matoba M, Magnusson Y, et al. (1994) Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol 72(1): 15-20.